AngioDynamics Company Profile (NASDAQ:ANGO)

Analyst Ratings

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $14.10 (15.21% downside)

Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
Show:
DateFirmActionRatingPrice TargetActions
4/8/2016KeyCorpLower Price TargetOverweight$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Piper Jaffray Cos.Initiated CoverageNeutral$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Canaccord GenuityDowngradeBuy -> Hold$14.50 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2015SidotiInitiated CoverageNeutral$14.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for AngioDynamics (NASDAQ:ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/6/2016        
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/7/2016Q3$0.14$0.15$87.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/8/2015Q116$0.11$0.11$83.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/9/2015Q315$0.16$0.12$86.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/9/2014Q115$0.11$0.16$87.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/12/2012$0.08$0.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/4/2012$0.07$0.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/5/2012$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/6/2011$0.09$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/14/2011$0.10$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/5/2011$0.12$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/4/2011$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.12$0.15$0.14
Q2 20162$0.16$0.17$0.17
Q1 20171$0.12$0.12$0.12
Q2 20171$0.15$0.15$0.15
Q3 20171$0.17$0.17$0.17
Q4 20171$0.19$0.19$0.19
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AngioDynamics (NASDAQ:ANGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AngioDynamics (NASDAQ:ANGO)
DateHeadline
07/27/16 10:44 AMAngioDynamics : Issues Statement Regarding Stryker recall of Angiographic Catheters
07/25/16 08:34 PMAngioDynamics names new CFO
07/25/16 12:17 PMETF’s with exposure to AngioDynamics, Inc. : July 25, 2016 -
07/25/16 06:48 AMAngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer - [at noodls] - July 25, 2016 Greiner brings more than 20 years of accounting, corporate finance and operations experience from a variety of global corporations ALBANY, N.Y., July 25, 2016 (GLOBE NEWSWIRE) -- AngioDynamics ...
07/22/16 10:17 AMAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2016 By the Numbers : July 22, 2016 -
07/22/16 08:06 AMAngioDynamics, Inc. :ANGO-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 -
07/20/16 09:58 PMAngioDynamics Inc. (ANGO) Hits New 52-week High During July 18 Session
07/13/16 07:59 PMAngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
07/13/16 07:59 PMAngioDynamics new CEO looks to growth opportunities after 2016 loss
07/13/16 07:59 PMAngioDynamics : reports 4Q loss
07/13/16 07:59 PMAngioDynamics revenue beats but outlook lags
07/13/16 07:59 PMAngioDynamics Inc. (ANGO) Jumps 9.93% on July 13
07/13/16 01:40 PMEdited Transcript of ANGO earnings conference call or presentation 13-Jul-16 12:00pm GMT -
07/13/16 09:15 AMThe Market In 5 Minutes: Indexes Are At All-Time Highs - Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in five minutes. Apply for daily AM access by clicking here or email [email protected] Macro Focus The Dow Jones industrial average closed at a record high Tuesday, a day after the S&P 500 index did the same. The gains were led by energy, materials and finance companies. The Dow closed at 18,347.26, up 120 points. The S&P 500 closed at 2,152.14, up about 15 points from Monday's record close. Oil production from the Middle East has climbed to a record while U.S. output slumps, the International Energy Agency said, in a sign that OPEC’s strategy of defending market share is succeeding. Middle Eastern output exceeded 31 million barrels a day for a third month in June amid near-record supply from Saudi Arabia, while U.S. oil production slid 140,000 barrels a day to 12.45 million USA Export Price Index (MoM) for June 0.80 percent vs 0.40 percent Est. USA Import Price Index (MoM) for June 0.20 percent vs 0.50 percent Est. The Federal Reserve Beige Book is due out 2:00 p.m. ET. BZ News Desk Focus AAR (NYSE: AIR) Reports Q4 EPS $0.34 vs. Est. $0.47, Rev. $458.2M vs. Est. $452.4M AngioDynamics (NASDAQ: ANGO) Reports Q4 Adj. EPS $0.19 vs ...Full story available on Benzinga.com
07/13/16 06:07 AMQ4 2016 AngioDynamics Inc Earnings Release - Before Market Open -
07/13/16 05:23 AMAngioDynamics reports 4Q loss -
07/12/16 07:58 PMAngioDynamics Inc. (ANGO) is Trading Lower on Unusual Volume for July 11
07/08/16 09:25 AMCan AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise? -
07/01/16 04:51 PMETF’s with exposure to AngioDynamics, Inc. : July 1, 2016 -
06/29/16 10:43 AMAngioDynamics Inc.: AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results
06/29/16 05:00 AMAngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results - [GlobeNewswire] - ALBANY, N.Y., June 29, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced ...
06/17/16 04:05 PMETF’s with exposure to AngioDynamics, Inc. : June 17, 2016 -
06/14/16 09:18 AMAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers : June 14, 2016 -
05/18/16 07:17 AMAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : May 18, 2016 -
04/28/16 11:24 AMPAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell - [at noodls] - ADVISORY, April 28, 2016 (GLOBE NEWSWIRE) -- What: PAVmed Inc. (Nasdaq:PAVMU), a multi-product medical device company bringing innovative medical technologies from concept to commercialization with unprecedented ...
04/28/16 06:15 AMAngioDynamics releases details of ex-CEO's severance package -
04/27/16 03:16 PMANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
04/21/16 08:20 AM2 more executives leave one of Albany's biggest public companies -
04/21/16 08:08 AMNew AngioDynamics CEO: I'll focus on current business now, M&A next phase -
04/20/16 09:57 AMAngioDynamics finance chief bids adieu, commercial chief axed -
04/20/16 07:51 AMANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers -
04/14/16 01:47 PMETF’s with exposure to AngioDynamics, Inc. : April 14, 2016 -
04/13/16 08:24 AMAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers -
04/12/16 02:23 PMAngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : April 12, 2016 -
04/11/16 07:15 AMAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 11, 2016 -
03/29/16 05:53 AMAngioDynamics To Report Fiscal 2016 Third Quarter Financial Results - ALBANY, N.Y., March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report ...
03/10/16 05:30 AMAngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients - [GlobeNewswire] - ALBANY, N.Y., March 10, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...
03/07/16 07:04 AMAngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 7, 2016 -
03/07/16 05:30 AMAngioDynamics to Present at the Barclays Global Healthcare Conference - [GlobeNewswire] - ALBANY, N.Y., March 07, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...
02/16/16 08:21 AMStrong Investor Participation and Presentations at Long Island Capital Alliance Healthcare Capital Forum - [Marketwired] - The Long Island Capital Alliance , Long Island's leading non-profit capital formation and business development organization, today announced the successful completion of its Healthcare Capital Forum held ...
02/10/16 01:30 PMGov. Cuomo seeks to reframe $15 billion cost of minimum wage as 'reinvestment' -
02/09/16 03:20 PMAngioDynamics: Health Canada Okays Celerity with Navigation -
02/09/16 01:32 PMAngioDynamics wins Health Canada nod for new Celerity device - AngioDynamics (NSDQ:ANGO) said today that it won approval from Health Canada ... CCSI Distributors, a subsidiary of Clinical Computer Systems Inc., announced their partnership with OB-Tools. This relationship provides exclusive distribution rights for ...
02/08/16 05:31 AM6:31 am AngioDynamics announces Health Canada approval of the Celerity PICC Tip Confirmation System with navigation -
02/08/16 05:30 AMAngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada - [GlobeNewswire] - ALBANY, N.Y., Feb. 08, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...
01/20/16 10:10 AMAngioDynamics, Inc. Earnings Analysis: Q2, 2016 By the Numbers -
01/07/16 09:32 PMEdited Transcript of ANGO earnings conference call or presentation 7-Jan-16 9:30pm GMT -
01/07/16 03:20 PMAngioDynamics Reports Fiscal 2016 Second Quarter Results - [at noodls] - January 7, 2016 Net sales of GAAP loss of per share; Non-GAAP adjusted EPS of Operating cash generation of , (GLOBE NEWSWIRE) -- (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical ...
01/07/16 03:19 PMANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit -
01/07/16 03:13 PMAngioDynamics reports 2Q loss -

Social

About AngioDynamics

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include fluid management, venous, thrombus management, as well as other core products. The Company's BioFlo products incorporate Endexo technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its microwave ablation products, its radiofrequency ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ANGO
  • CUSIP: 03475V10
Key Metrics:
  • Previous Close: $16.63
  • 50 Day Moving Average: $14.55
  • 200 Day Moving Average: $12.27
  • P/E Ratio: N/A
  • P/E Growth: 1.47
  • Market Cap: $595.82M
  • Beta: 0.9
  • Current Year EPS Consensus Estimate: $0.63 EPS
  • Next Year EPS Consensus Estimate: $0.71 EPS
Additional Links:
AngioDynamics (NASDAQ:ANGO) Chart for Wednesday, July, 27, 2016